- POSITIVE
Annual Revenue Asarfi Hospital Mar-2026 Annual Revenue is Rs 176 Cr which is growth of 37.3% YoY.
- POSITIVE
Annual Net Profit Asarfi Hospital Mar-2026 Annual Net Profit is Rs 17 Cr which is growth of 55.5% YoY.
BSE: 543943
Asarfi Hospital Live Share Price Today, Share Analysis and Chart
aboutAsarfi Hospital Ltd. is a healthcare provider primarily operating in Dhanbad, Jharkhand. The company operates as a multispecialty healthcare facility providing a range of medical services including tertiary care. It serves the regional population wit... Read More
173.20-6.75(-3.75%)
34,000
BSE Volume
BSE 19 Nov, 2026 3:31 PM
Asarfi Hospital Stock Price Ranges
Day Price Range-3.8% 1 Day return | 173.2 (LTP) 173180 LowHigh |
|---|---|
Week Price Range-5.4% 1 Week return | 173.2 (LTP) 173198.4 LowHigh |
Month Price Range-9.5% 1 Month return | 173.2 (LTP) 155198.4 LowHigh |
52 Week Price Range-15.2% 1 Year return | 173.2 (LTP) 147.7257 LowHigh |
Peers
Quarterly
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Asarfi Hospital annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
37.4%
2Y CAGR
43%
3Y CAGR
34.1%
5Y CAGR
26.5%
Total Revenue Annual growth is higher than historical averages.
Net Profit Ann.
1Y CHG
55.5%
2Y CAGR
101.8%
3Y CAGR
28.8%
5Y CAGR
37.3%
Net Profit Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
42.4%
2Y CAGR
42%
3Y CAGR
34.3%
5Y CAGR
24.5%
Operating Expenses Annual Cr growth is higher than historical averages.
Asarfi Hospital Technical Analysis
Asarfi Hospital EMA & SMA
Bearish-8
Bullish0
Bearish8
| 5 Day | 179.5 |
|---|---|
| 10 Day | 180.0 |
| 12 Day | 179.9 |
| 20 Day | 179.8 |
| 26 Day | 180.4 |
|---|---|
| 50 Day | 184.9 |
| 100 Day | 191.5 |
| 200 Day | 189.3 |
Asarfi Hospital Delivery And Volume
Daily Avg. Delivery Volume %
19 Nov, 202652.9%
Week73.9%
Month75.3%
PositiveNeutralNegative
Asarfi Hospital Resistance and Support
175.40
Pivot
| First Resistance | 177.8 |
|---|---|
| Second Resistance | 182.4 |
| Third Resistance | 184.8 |
| First Support | 170.8 |
|---|---|
| Second Support | 168.4 |
| Third Support | 163.8 |
| Day RSI | 44.5 |
|---|---|
| Day MACD | -0.5 |
| Day MFI | 72.5 |
| Day MACD Signal Line | -1.2 |
Asarfi Hospital Beta
| 1 Month | 1.9 |
|---|---|
| 1 Year | 0.9 |
| 3 Month | 0.8 |
|---|---|
| 3 Year | 0.2 |
Asarfi Hospital Price Change Analysis
↓-9.5%
Over 1 Month
LowHigh
155.0198.5
↓-29.0%
Over 3 Months
LowHigh
155.0248.4
↓-11.4%
Over 6 Months
LowHigh
155.0248.4
↓-15.2%
Over 1 Year
LowHigh
147.7257.0
Asarfi Hospital Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| HARISHKUMARGUPTA | Bulk | Sell | 23 May 2025 | 106.99 | 100,000 | BSE |
| HARISHKUMARGUPTA | Bulk | Purchase | 09 May 2025 | 106.94 | 100,000 | BSE |
| ULTRA SIGMA PRIVATE LIMITED | Bulk | Purchase | 18 Mar 2025 | 79.38 | 100,000 | BSE |
| NEW BERRY ADVISORS LTD | Bulk | Sell | 18 Mar 2025 | 79.38 | 100,000 | BSE |
| ANG CORPORATE SERVICES PVT LTD | Bulk | Purchase | 15 Mar 2024 | 60.96 | 200,000 | BSE |
| VALUE PROLIFIC CONSULTING SERVICES PVT LTD | Bulk | Sell | 15 Mar 2024 | 60.96 | 200,000 | BSE |
| NAMRATA CHANDRAPRAKASH KHANDELWAL | Bulk | Sell | 07 Mar 2024 | 72.09 | 119,000 | BSE |
| JINENDRA KUMAR JAIN | Bulk | Purchase | 07 Mar 2024 | 72.10 | 116,000 | BSE |
| VINEY EQUITY MARKET LLP | Bulk | Sell | 19 Jan 2024 | 96.03 | 155,000 | BSE |
| NAMRATA CHANDRAPRAKASH KHANDELWAL | Bulk | Purchase | 19 Jan 2024 | 96.04 | 140,000 | BSE |
Asarfi Hospital Corporate Actions
Asarfi Hospital Board Meetings
Asarfi Hospital past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
113 Nov 2026 | Half Yearly Results | - |
225 Aug 2026 | A.G.M. | - |
307 Aug 2026 | Quarterly Results | - |
411 May 2026 | Audited Results | - |
509 Feb 2026 | Quarterly Results | - |
Asarfi Hospital Corporate Filings
Asarfi Hospital BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 19 Nov 2026 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | We wish to inform you that Asarfi Hospital Limited has scheduled a Conference Call with Analysts / Investors on Tuesday, November 24, 2026, at 04:00 P.M. (IST) to discuss the Audited Financial Results of the Company for the quarter and half year ended September 30, 2026. | |
| 14 Nov 2026 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | Outcome of Press Release/Media Release Under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015. | |
| 13 Nov 2026 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | Submission of Press Release of the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30 September 2026. | |
| 13 Nov 2026 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Investor Presentation | Submission of Investor Presentation of Asarfi Hospital Limited for the Quarter & Half Year ended September 30,2026. | |
| 13 Nov 2026 | Asarfi Hospital Ltd - 543943 - Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026 | We wish to inform you that the Board of Directors of Asarfi Hospital Limited at its meeting held today i:e, 13th November 2026, has considered and approved the unaudited Standalone and Consolidated Financial Results of the company for the quarter ended 30th September 2026. |
Asarfi Hospital Documents
Asarfi Hospital Earnings Call
Asarfi Hospital earnings calls, including management commentary and AI-generated summaries.
| Date | Title | Links |
|---|---|---|
| 30 May 2026 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | |
| 22 Nov 2025 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | |
| 14 May 2025 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Ai summaryPdf |
| 09 Nov 2024 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Ai summaryPdf |
| 06 Nov 2024 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
Asarfi Hospital Annual Reports
Asarfi Hospital financials, including annual results, balance sheets, and cash flow statements.
Asarfi Hospital Credit Ratings
Asarfi Hospital credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.
| Date | Rating Agency | Company Name | Description | Links |
|---|---|---|---|---|
| 06 Oct 2026 | crisil ratings | Asarfi Hospital Limited | Asarfi Hospital Limited:Long-term rating upgraded to 'Crisil BBB / Stable'; 'Crisil A3+' assigned to short-term bank debt; Rated amount enhanced for Bank Debt | Link |
| 09 Oct 2025 | crisil ratings | Asarfi Hospital Limited | Asarfi Hospital Limited:'Crisil BBB-/Stable' assigned to Bank Debt | Link |
| 25 Sep 2025 | care ratings | Asarfi Hospital Limited | ||
| 05 Sep 2024 | care ratings | Asarfi Hospital Limited | ||
| 15 May 2024 | care ratings | Asarfi Hospital Limited |
Asarfi Hospital Investor Presentations
Asarfi Hospital investor presentations, including business updates, financial insights, and strategic initiatives.
| Date | Report Title | Links |
|---|---|---|
| 13 Nov 2026 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Investor Presentation | |
| 07 Aug 2026 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Investor Presentation | |
| 11 May 2026 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Investor Presentation | |
| 09 Feb 2026 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Investor Presentation | |
| 10 Nov 2025 | Asarfi Hospital Ltd - 543943 - Announcement under Regulation 30 (LODR)-Investor Presentation |
Asarfi Hospital - Company Profile
Asarfi Hospital Management Structure
Asarfi Hospital management structure with salaries, total experience, and qualifications.
Asarfi Hospital Board of Directors
Asarfi Hospital Board of directors with salaries, total experience, and qualifications.
Website: www.asarfi.in
About the company - Business Profile
Asarfi Hospital Ltd. is a healthcare provider primarily operating in Dhanbad, Jharkhand. The company operates as a multispecialty healthcare facility providing a range of medical services including tertiary care. It serves the regional population with specialized departments such as Cardiology, Neurosciences, Oncology, and General Surgery. The company recently expanded its operations by operationalizing a dedicated Cancer Hospital unit in late 2024, significantly enhancing its service portfolio.
Key Points
- Key Facts: Founded in 2005 and headquartered in Dhanbad, Jharkhand, Asarfi Hospital Ltd. is listed on the BSE (Scrip Code: 543943). It operates as a primary healthcare entity in its region.
- Operations and Resources: The company operates a Super-Specialty Hospital unit and a newly established Cancer Hospital unit. As of late 2025, the total bed capacity across both units stood at 330, with 277 effective beds.
- Ownership: The promoter group holds a 61.17% stake in the company as of March 2025. The remaining shares are held by public shareholders, including Alternative Investment Funds (AIF) and individual investors.
- Market and Significance: Asarfi Hospital is a critical healthcare provider in the Dhanbad region, offering specialized treatments that were previously less accessible locally. Its strategic importance is underlined by its role as a super-specialty center in Jharkhand.
- Business Model and Core Competencies: The company follows a healthcare service model, generating revenue through In-Patient Department (IPD) and Out-Patient Department (OPD) services, as well as the sale of medicines. It excels in delivering specialized surgical and medical interventions, particularly in cardiology and oncology.
- Revenue Breakdown (FY2025 - Annual):
- Hospital and Medical Care: ₹11,356.63 Lakhs (94.20% of total turnover).
- Trade of Medicine: ₹699.95 Lakhs (6.75% of total turnover).
- Geographical Focus: Operations are concentrated in Dhanbad, Jharkhand, India.
- Key Products and Technology:
- The company has implemented advanced diagnostic and surgical tools, including Intravascular Ultrasound (IVUS) for intracoronary imaging, expected to be fully operational by March 2026.
- Specialized units include Medical Oncology, Surgical Oncology, and Radiation Oncology.
- Subsidiaries: The company has a wholly-owned subsidiary, Asarfi Educational Foundation, which focuses on medical education and training.
- Strategic Initiatives:
- Operationalization of the new Cancer Hospital to capture the growing demand for oncology services.
- Integration of advanced medical technologies like IVUS to improve clinical outcomes and premium procedural billings.
- Focus on increasing Average Revenue Per Occupied Bed (ARPOB), which rose to ₹24,293 for the Super-Specialty unit and ₹43,240 for the Cancer unit in Q3 FY2026.
- Future Outlook: The company aims for higher patient retention and referral growth through its specialized cancer care and advanced cardiac imaging capabilities.
Financial Performance (FY2025 Consolidated)
- Total Income: ₹12,809 Lakhs (48% YoY growth compared to ₹8,607 Lakhs in FY2024).
- EBITDA: ₹2,355 Lakhs with an EBITDA Margin of 19%.
- PAT: ₹1,058 Lakhs with a PAT Margin of 9% (compared to ₹416 Lakhs in FY2024).
References
